Alkermes PLC (NAS:ALKS)
$ 24.34 -0.04 (-0.16%) Market Cap: 4.12 Bil Enterprise Value: 3.74 Bil PE Ratio: 9.62 PB Ratio: 3.28 GF Score: 66/100

Alkermes Plc at Goldman Sachs Global Healthcare Conference Transcript

Jun 15, 2022 / 09:40PM GMT
Release Date Price: $25.69 (+1.62%)
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

So let's get underway. Good afternoon, everybody. Welcome to Goldman Sachs Healthcare Conference Wednesday afternoon. My name is Chris Shibutani. I'm a member of the Goldman Sachs research team, pharmaceuticals and biotech. We are very excited to welcome Alkermes once again to join us. And I am very pleased and excited to be in-person, seated opposite Richard. Once again, Richard it's fantastic to see you.

Richard F. Pops
Alkermes plc - Chairman & CEO

Likewise.

Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Thank you for joining us. You're joined at this event by our Chief Financial Officer. Iain is out there, he's waving. And then, of course, Sandy, who everybody knows, keeps everybody on top of things as always, and the voice of reason and keeps everybody on schedule. So much appreciated, Sandy.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot